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Abstract 
The aims of the current study were to examine, prospectively, 1) dynamic changes in affective 
state, self-efficacy, and urge in the hours before initial smoking and drinking lapses among 
individuals in concurrent alcohol and smoking treatment, and 2) the extent to which self-
efficacy, urge to use, and/or the use of one substance predicted lapse to the other substance. 
Ninety-six men and women recruited for a clinical trial of concurrent alcohol and tobacco 
treatment were eligible for inclusion. Only data from those who experienced an initial lapse to 
drinking (n=29), or smoking (n=32) were included. Two outpatient substance abuse clinics 
provided concurrent alcohol and smoking treatment on a weekly basis for three months. 
Ecological Momentary Assessment (EMA) methods were employed over a 28-day monitoring 
period to assess antecedents to first drink and a 14-day monitoring period was examined for 
initial smoking lapses. Baseline and EMA measures of positive and negative affect, 
alcohol/smoking urge, alcohol/smoking abstinence self-efficacy, nicotine withdrawal, and 
quantity/frequency of alcohol and tobacco use were examined as lapse predictors. Analyses of 
EMA ratings controlled for the corresponding baseline measure. Smoking lapse among 
individuals in concurrent alcohol and tobacco treatment was foreshadowed by higher urges to 
smoke, lower positive mood, and lower confidence to resist smoking. Drinking lapse was 
preceded by lower confidence to resist smoking, but only among individuals who reported recent 
smoking. Concurrent alcohol and smoking treatment should focus on the enhancement of 
abstinence self-efficacy, positive mood, and the curbing of urges in order to offset lapse risk. 
KEYWORDS: alcoholism treatment, smoking cessation, ecological momentary assessment, 
smoking relapse, drinking relapse 
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Prospective Analysis of Early Lapse to Drinking and Smoking 
 Among Individuals in Concurrent Alcohol and Tobacco Treatment 
Studies have shown that 56-65% of adults with alcohol abuse or dependence are current 
smokers (Daeppen et al., 2000; Lasser et al., 2000), which is nearly three times the rate (21%) in 
the general population (Pleis, Lucas, & Ward, 2009). Those with alcohol problems who smoke 
also are more dependent on nicotine, report lower smoking quit rates than those without alcohol 
problems (Hughes & Kalman, 2006), and die more often from diseases associated with cigarette 
smoking as opposed to alcohol-related causes (Hurt et al., 1996). Accordingly, the United States 
Department of Health and Human Services (Fiore et al., 2008) has recommended that smoking 
cessation be offered in the context of other substance abuse treatment. Although this is the 
recommended approach, concurrent treatment for alcohol and tobacco may pose unique 
challenges. For example, coping with withdrawal symptoms from both substances might impede 
treatment success (Joseph, Willenbring, Nugent, & Nelson, 2004). Alternatively, if one 
substance has become a conditioned stimulus for the use of the other, or if one substance elicits 
craving for the other substance (Istvan & Matarazzo, 1984; Littleton, Barron, Prendergast, & Jo 
Nixon, 2007), concurrent treatment may lead people to achieve abstinence from both substances 
more easily than would be expected from the treatment of one substance alone.   
Outcome research has explored whether concurrent treatment leads to higher or lower 
rates of abstinence from tobacco and other substances compared to substance abuse or tobacco 
treatment alone (see Kodl, Fu, & Joseph, 2006 for a review). A meta-analysis of 11 randomized 
controlled trials of concurrent treatment for tobacco and other substances showed that those who 
received concurrent substance and tobacco treatment were 25% more likely to show long-term 
abstinence from alcohol and drugs than control participants who received substance treatment 
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without tobacco treatment. However, there was no difference in long-term smoking abstinence 
rates (Prochaska, Delucchi, & Hall, 2004). In contrast, one well-designed study found that 
concurrent alcohol and tobacco treatment led to significantly lower alcohol abstinence rates 
following treatment compared to alcohol treatment with tobacco treatment deferred for six 
months (Joseph et al., 2004). While these outcome studies largely support the provision of 
concurrent treatment, there is little research on the process of lapse and relapse in this context 
(although see Cooney et al., 2007).  
A careful examination of the lapse and relapse process among individuals aiming to quit 
smoking and drinking is important for several reasons: First, determining the extent to which 
dynamic changes in cognitive and affective variables are associated with initial lapses to tobacco 
and alcohol can advance theories of relapse, subsequently leading to the development of more 
effective interventions and relapse prevention strategies for individuals with comorbid alcohol 
and tobacco dependence. Traditionally, research on relapse has focused on traits, or stable 
characteristics of the individual that place them at risk for relapse (Shiffman, 2005). Since traits 
are, by definition, enduring characteristics, it may be more fruitful to examine factors that are 
more proximal and, therefore, potentially modifiable through intervention (Shiffman, 2005). 
 Second, an investigation of the factors leading up to early lapse among individuals in 
concurrent treatment affords researchers the unique opportunity to explore whether common 
factors are associated with lapse to both substances (e.g., do increases in negative affect predict 
both smoking and drinking lapse?), whether variables related to one substance are precursors of 
relapse to another substance (e.g., does cigarette urge increase the likelihood of a drinking 
lapse?), and the extent to which a lapse to one substance increases the risk of a lapse to another 
substance (e.g., does smoking lapse increase likelihood of a drinking lapse?).    
PROSPECTIVE ANALYSIS OF EARLY LAPSE                                                                       5 
 
The cognitive-behavioral model of lapse and relapse (Marlatt & Gordon, 1985; 
Witkiewitz & Marlatt, 2004) identifies several key intrapersonal factors, namely affective state, 
abstinence self-efficacy, and urge (or craving) as proximal determinants of alcohol and smoking 
lapse and relapse. Research on these factors often has been based on retrospective reports 
collected long after the lapse or relapse episode (e.g., Lowman, Allen, & Stout, 1996; Zhou et al., 
2009). These reports are subject to recall errors and bias, and have been demonstrated to be 
inaccurate (Shiffman et al., 1997a). In contrast, ecological momentary assessment (EMA; 
Shiffman, Stone, & Hufford, 2008; Shiffman, 2009) methodology involves frequent sampling of 
participants’ cognitions and behaviors in their natural environments, in near real-time. Some 
EMA studies have asked participants to record details of a lapse right after it was over (Ferguson 
& Shiffman, 2010; Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). This method may reduce 
retrospection bias, but it does not eliminate it. A small number of studies have employed a 
prospective analysis of EMA data, examining reports obtained during the day or hours just 
before the lapse episode. In this article we employed the latter approach and report on a 
prospective analysis of proximal measures of affective state, abstinence self-efficacy, and urge in 
the hours before first drinking and smoking lapses.  
Affective state is a key component of one prominent theoretical model of relapse, which 
asserts that substance relapse is prompted largely by negative reinforcement, or as a means of 
coping with drug withdrawal (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004). According to 
this model, smoking or drinking lapses are most likely to occur in the context of rising negative 
mood states or falling positive mood states. In a prospective EMA study of smoking treatment 
(Shiffman & Waters, 2004) negative affect (NA) ratings collected across one day did not predict 
smoking lapse on the next day. Also, there was no significant trend in NA in the four days 
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leading up to first smoking lapse. However, NA in the hours before was a marginal predictor of 
first smoking lapse. Moreover, for smoking lapses attributed to stress, NA in hours before the 
lapse was a strong predictor of first smoking lapse. In addition, a previous study of concurrent 
alcohol and tobacco treatment found that prospective EMA ratings of negative high arousal 
mood obtained hours earlier predicted smoking lapse (Cooney et al., 2007). However, 
prospective NA ratings did not predict drinking lapse. Taken together, EMA ratings of negative 
affect appear to be influential in smoking lapses; the role of NA in drinking lapses is less clear.  
With respect to positive affect, research has shown that lower baseline levels of positive 
affect were associated with shorter time to smoking relapse following a smoking quit attempt 
(Leventhal, Ramsey, Brown, LaChance, & Kahler, 2008) and following smoking treatment 
(Doran et al., 2006). Moreover, among smokers with a history of depression, anhedonia was a 
significant predictor of smoking relapse, even after controlling for depressive symptoms prior to 
quitting (Cook, Spring, McChargue, & Doran, 2010). Interestingly, a recent review paper noted 
that both anhedonia and low levels of positive affect were more consistent predictors of smoking 
relapse when compared to negative affect and anxious arousal (Ameringer & Leventhal, 2010), 
suggesting that negative and positive affect should be regarded as unique predictors of smoking 
relapse. Findings from Borland (1990) further support this distinction, as positive and negative 
mood states served as lapse triggers with similar frequency (32% and 35%, respectively) among 
smokers making a quit attempt.   
In contrast to the inverse relation between positive affect and relapse frequently reported 
in the smoking literature, some studies examining the relation between positive affect and 
drinking have shown a positive relation between these variables. For example, EMA measures of 
positive affect were positively associated with alcohol consumption later in the day among 
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moderate to heavy college drinkers (Simons et al., 2005; Simons et al., 2010) and predicted 
excessive drinking in heavy drinking adults (Collins et al., 1998). Findings among people 
diagnosed with alcohol dependence, however, are mixed: positive mood was retrospectively 
reported as a trigger for some drinking lapses and relapses (Hodgins, el-Guebaly, & Armstrong, 
1995), however, in another study, daily measures of positive affect were not associated with 
treatment outcomes (Oslin, Cary, Slaymaker, Colleran, & Blow, 2009). Additional research is 
needed to determine whether there is a relation between positive affect and drinking lapses in 
persons with alcohol use disorders.  
Another potential determinant of lapse and relapse from the cognitive-behavioral model 
is urge to use, or craving. A prospective EMA smoking treatment study found that urge to smoke 
upon waking in the morning significantly predicted first smoking lapse later in the day (Shiffman 
et al., 1997b). Smoking urges assessed one day earlier also predicted first smoking lapse after 
controlling for baseline smoking urge intensity. In a previous concurrent alcohol tobacco 
treatment study (Cooney et al., 2007), prospective EMA ratings of higher smoking urge assessed 
hours earlier predicted first smoking lapse and drinking lapse, suggesting that urges might not 
need to be substance-specific to threaten abstinence. Interestingly, urge to drink was not a 
significant predictor of either type of lapse. 
A low level of abstinence self-efficacy (ASE) is another key factor associated with 
smoking and drinking lapses. Self-efficacy has been examined as a prospective predictor of 
smoking lapse in four EMA studies. Shiffman et al. (2000) followed participants enrolled in a 
smoking cessation research clinic. Lower average daily smoking ASE predicted the first smoking 
lapse on the next day, but this prediction did not hold up after controlling for differences in 
baseline ASE, suggesting that between-person differences in ASE, not within-person variation in 
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ASE, accounted for lapse risk. Gwaltney, Shiffman, Balabanis, and Paty (2005) followed a 
similar sample of participants and found that EMA reports of lower smoking ASE averaged 
across a day predicted first smoking lapse on the next day, even after controlling for differences 
in baseline ASE. Van Zundert, Ferguson, Shiffman, and Engels (2010) collected EMA reports 
from a sample of adolescent smokers who were trying to quit unaided. Lower daily smoking 
ASE predicted the first smoking lapse on next day, even after controlling for differences in 
baseline ASE. In a previous study of concurrent alcohol and tobacco treatment (Cooney et al., 
2007) lower alcohol ASE assessed hours earlier predicted first drinking lapse, as was 
hypothesized. Smoking ASE was not assessed in that study. 
To elucidate precursors to lapses and possible cross-substance interactions, the current 
study examined whether momentary measures of key intrapersonal factors (i.e., positive/negative 
affect, urge to smoke or drink, abstinence self-efficacy) predicted initial drinking and smoking 
lapses among individuals enrolled in a clinical trial of concurrent alcohol and tobacco treatment. 
Outcome data from this trial were reported in a previous report (Cooney et al., 2009). 
Specifically, it was hypothesized that momentary measures of negative affect and urge would be 
positively associated with smoking and drinking lapses, momentary measures of abstinence self-
efficacy would be inversely associated with smoking and drinking lapses, and the momentary 
measure of positive affect would be inversely associated with smoking lapse. The current study 
also examined the extent to which ASE, urge, and/or the use of one substance predicted lapse to 
the other substance. Due to the paucity of research on cross-substance interactions in this context 
and the mixed findings regarding the role of positive affect in drinking lapses, no specific 
hypotheses regarding these relations were made. 
Method 
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Participants and Procedure 
Participants were 48 men and women who experienced a smoking (n=32) and/or drinking 
lapse (n=29) during an intensive one-month EMA monitoring period as part of a clinical trial of 
concurrent alcohol and tobacco treatment. Participants in the current study were a subset of the 
total number enrolled in the clinical trial (N=96). The methods for this trial are described in 
detail elsewhere (Cooney, et al., 2009). Briefly, two outpatient substance abuse treatment sites 
provided a platform of behavioral alcohol and smoking treatment delivered in three months of 
weekly one-hour sessions followed by three monthly booster sessions. Participants were 
randomly assigned to receive either nicotine patch and active nicotine gum or nicotine patch and 
placebo gum. Primary inclusion criteria were a DSM-IV diagnosis of alcohol abuse or 
dependence and a smoking rate of >15 cigarettes per day. Individuals with medical 
contraindications for nicotine replacement therapy, those taking medications known to influence 
alcohol or tobacco use (e.g., naltrexone, disulfiram, bupropion), and those with opiate or 
benzodiazepine abuse or dependence or intravenous drug abuse in the past year were excluded. 
When alcohol detoxification was necessary, it was completed prior to study enrollment. Table 1 
summarizes the characteristics of the sample that provided data for the present study. 
Participants’ alcohol use was relatively heavy, with drinking reported on 72% of days, and the 
majority of days involving heavy drinking. Smoking rates also were fairly high, with participants 
smoking an average of 25 cigarettes per day, and a mean FTND score of 6.5, considered in the 
high dependence range (Fagerstrom, Heatherton, & Kozlowski, 1991).  
Baseline Measures 
The following baseline measures were obtained immediately after informed consent and 
study enrollment, prior to the start of alcohol-tobacco treatment. At this point participants were 
PROSPECTIVE ANALYSIS OF EARLY LAPSE                                                                       10 
 
abstinent from alcohol but were still smoking at baseline rates. 
Affect. The 20-item Center for Epidemiologic Studies – Depression Scale was 
administered to assess negative affect (CES-D, Radloff, 1977). Although the entire CES-D scale 
was administered (α = .77 in this study), we used the seven-item Depressed Affect subscale 
(Shafer, 2006) as a baseline measure of negative affect, given that it likely captured this 
construct with a higher level of specificity than the total CES-D score. The internal consistency 
reliability of the Depressed Affect subscale in our study was good (α = .87). The Vigor-Activity 
scale from an abbreviated 30-item form of the Profile of Mood States (McNair, Lorr, & 
Droppelman, 1992) was used to assess baseline positive affect (PA). This scale consists of five 
items (lively, active, energetic, sluggish, weary) and is considered to be an indicator of global PA 
(Ameringer & Leventhal, 2010). Internal reliability of the scale in our sample was α = .93. 
Craving. The five-item Penn Alcohol Craving Scale (PACS; Flannery, Volpicelli, & 
Pettinati, 1999) was administered to assess baseline alcohol craving, as well as the ability to 
resist alcohol if it were available (α = .89). Baseline cigarette craving was assessed with the 32-
item Questionnaire of Smoking Urges (QSU; Tiffany & Drobes, 1991) (α = .94 in the current 
study). 
Self-efficacy. Nine items from the Smoking Self-Efficacy/Temptation (SSE-T) scale 
were used to assess baseline smoking abstinence self-efficacy (α = .86). The SSE-T asks 
respondent to rate how tempted they would be to smoke across a variety of situations (see 
http://www.uri.edu/research/cprc/Measures/Smoking02.htm for 9-item scoring instructions; 
Velicer, DiClemente, Rossi, & Prochaska, 1990). The Alcohol Abstinence Self-Efficacy Scale 
(AASE; DiClemente, Carbonari, Montgomery, & Hughes, 1994) was used to assess baseline 
alcohol abstinence self-efficacy. The AASE inquires about temptation and confidence across 20 
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different drinking situations. Total abstinence self-efficacy was calculated as Confidence - 
Temptation (α = .92).  
Nicotine withdrawal. The Minnesota Nicotine Withdrawal Scale (MNWS; Hughes & 
Hatsukami, 1986) was administered at baseline to measures the severity of eight withdrawal 
symptoms on 5-point Likert scales (α = .88).   
Ecological Momentary Assessment (EMA) 
EMA was conducted for four weeks beginning soon after the start of alcohol treatment 
but two weeks before smoking quit date, continuing for two weeks after the smoking quit date. 
Figure 1 shows the timing of the EMA measures relative to the other study procedures. 
Participants engaged in real-time in vivo monitoring using cellular telephones and an Interactive 
Voice Response (IVR) system. The IVR system was programmed to call participants five times 
per day and administer a 23-item questionnaire. Cellular telephones were issued to participants 
upon study entry, and participants were trained in their use. Cellular telephones were 
programmed so that participants could not make outgoing calls. 
Participants used the telephone numeric keypad to respond to questions asked by 
recorded voice. System hardware and software were provided and supported by Telesage, Inc., 
of Chapel Hill, NC. Participants engaged in signal-contingent assessment only. Time-based 
sampling procedures (Shiffman et al., 2008) were used, whereby participants were prompted to 
respond on a quasi-random basis, five times per day, with one randomly scheduled prompt in 
each of five time periods from 8:00AM to 10:00PM. Participants had the option of delaying 
responding to the cellular telephone for 5, 10 or 15 minutes when answering would be 
inconvenient. If a person was unavailable when the phone rang, the system called them back at 
later intervals. Responses were time-and-date-stamped, and entry of out-of-range data was 
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impossible. At the end of each assessment, the respondent was asked if all answers were correct 
and was able to correct any mistakes. Participants were unable to skip questions, making it 
impossible to complete the assessment with missing data. If data entry was abandoned in the 
midst of an assessment, the system called participant back to resume the assessment.  
For every call participants were prompted to record their responses using a 5-point scale 
ranging from 1=none to 5=very much. The program provided recorded questions pertaining to 
the participant’s “Urge to drink?”, “Urge to smoke?”, mood state, self-efficacy to resist smoking 
and drinking urges ("Confident that you can keep from drinking?" and "Confident that you can 
keep from smoking?"), smoking and drinking behavior, and use of nicotine gum. Mood 
assessment was based on items derived from the circumplex model of mood experience (Larsen 
& Diener, 1992), in which mood states are classed along two major dimensions: pleasantness 
(pleasant - unpleasant) and activation (high - low). Four quadrants of moods are thus created: 
positive-high activation items (active; peppy: α = .76); positive-low activation (quiet; relaxed: α 
= .72); negative-high activation (anxious or nervous; angry, irritable or frustrated: α = .81); and 
negative-low activation (depressed or sad; tired: α = .74). Negative mood subscales were 
correlated at r=.60 and positive mood subscales were correlated at r= .35. Negative and positive 
subscales were correlated in the range of -.30. A momentary withdrawal symptoms scale was 
calculated by taking the mean of the following momentary assessments: Sadness, Sleep 
Problems, Angry, Trouble Concentrating, Nervous, Hungry, Impatient, and Urge to Smoke. 
Because the content of this scale overlapped others, it was always treated independently in 
analyses. The internal reliability of the momentary scale was α = .76.  
Participants were paid $0.50 for each time they completed an IVR call.  They also were 
paid an additional $5.00 for each day that they completed all five scheduled IVR assessments. 
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The maximum total possible payment for IVR assessments was $210. The overall compliance 
rate with the EMA procedure over both phases was 65% of calls completed (range: 5% to 96%; 
24 cases responding below 40%). There appeared to be no relation between occurrence of 
smoking or drinking lapses and loss of recording adherence. Of those who recorded lapses to 
either substance during the 28-day EMA period, the mean number of records completed was 96, 
versus 98 for those who did not lapse. 
Data Analysis Plan 
Analyses were conducted to determine the momentary affective and cognitive 
antecedents of first drink and first cigarette after beginning treatment. Since participants were 
required to stop drinking prior to beginning treatment, the entire 28-day monitoring period was 
evaluated for occurrence of the first drink. In order to detect a “true” drinking lapse (as opposed 
to a continuation of an intermittent drinking phase), drinking lapse was defined as the first drink 
recorded after a period of at least 7 days of abstinence. Smoking lapse was defined as the first 
cigarette recorded during the monitoring period after the smoking quit date (i.e., days 14-28), and 
after a period of least 24 hours of smoking abstinence. Single puffs of a cigarette or sips of a 
drink were not regarded as lapses. Of the 96 persons treated, 29 met criteria for having a drinking 
lapse, 32 for having a smoking lapse, and 13 for both. Earlier analyses indicated that treatment 
condition did not influence predictors of lapse to either substance, so treatment condition was not 
included as a factor in the analyses that follow. 
Random effects logistic regressions were used in a within-subjects case-control design to 
evaluate predictors of occurrence of drinking lapse or smoking lapse. In these analyses, the IVR 
record in which either first drink or first cigarette was recorded was considered the “case” record. 
Records that preceded the “case” record served as “control” records (see, for example, Shiffman, 
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2009). Ratings from the participant’s IVR record immediately preceding the smoking or drinking 
lapse record were the predictors (i.e, lagged predictors). Thus, lagged predictors were used to 
determine the extent to which first cigarette or first drink was a function of affect, craving, or 
self-efficacy in the immediately preceding time period (up to 2.8 hours prior to the event). 
Lagged predictors had to be recorded on the same day as the event (i.e., affect or cognition 
scores from the evening before were not used to predict first cigarette or first drink the next 
morning). In analyses of determinants of first drink in the 28-day monitoring period, a total of 
658 records from 29 participants (i.e., 29 events) were analyzed. In analyses of antecedents of 
first cigarette in the second 14-day monitoring phase, a total of 368 records from 32 participants 
were analyzed.  
Analyses were conducted using generalized estimating equations (GEE) procedures (SAS 
Proc GENMOD; SAS, 1999). The GEE procedure was used because it is able to accommodate 
the multi-level, nested nature of the data. A logit link was used to characterize the outcome as 
having a binary distribution. Predictors included one of the relevant lagged affect or cognition 
variables (e.g., positive-high activation mood; confidence to resist drinking), day, time of day, 
and the interaction of day X time, to control for temporal variations in responding. The number 
of records completed by each participant, entered as a between-subjects variable, was used to 
control for IVR compliance levels. In addition, baseline values from questionnaires that provided 
an analog of each of the momentary predictor variables were entered to control for baseline 
between-subjects differences in responding, as per Kenny and Zautra (1995), who suggested that 
a person’s status on a given variable at a given time is a function of three sources of variance: a 
trait term that does not change over time; a state term that changes with circumstances, and a 
random error term. Neither the within-subjects temporal variables nor the between-subjects 
PROSPECTIVE ANALYSIS OF EARLY LAPSE                                                                       15 
 
records variable emerged as significant predictors of occurrence of events in the succeeding time 
period, so these variables are not referred to in the results below.  
Each of the planned lagged predictors was tested separately. Thus we conducted 10 
separate analyses, evaluating Negative – Low Activation Mood, Negative – High Activation 
Mood, Positive – Low Activation Mood, Positive – High Activation Mood, Confidence to Resist 
Smoking, Confidence to Resist Drinking, Urge to Smoke, Urge to Drink, Withdrawal Symptoms, 
and occurrence of smoking (or drinking), as predictors of first drink (or first cigarette). All 
analyses of lagged predictors controlled for the corresponding baseline measure. Because of the 
exploratory nature of these analyses no corrections were made for multiple tests. 
Results 
Predictors of Alcohol Lapse 
 Table 2 shows the results of the random effects logistic regression analyses conducted 
using first drink in the 28-day monitoring period as the dependent variable. As seen in the table, 
confidence to resist smoking emerged as a momentary predictor of first drink in the succeeding 
hours such that those who had high confidence in their ability to stop smoking were significantly 
less likely to have their first drink in the next few hours. Given the observed cross-substance 
predictive relation, we conducted a follow-up analysis to determine whether smoking status prior 
to the drinking lapse interacted with confidence to resist smoking to predict drinking lapse.  
Indeed, smoking status at time of first drink predicted occurrence of first drink, such that those 
who reported smoking one or more cigarettes in any of the IVR records prior to the drinking 
lapse (n=19) were 6 times more likely to have a drinking lapse during the 28-day monitoring 
period than those not smoking (Wald χ2=15.03, df=1, p<.001, OR=6.01, 95% CIs 2.44, 15.09). 
Moreover, as depicted in Figure 2, smoking status interacted with momentary confidence to 
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resist smoking to predict first drink, such that those who were still smoking, but had low self-
efficacy regarding their ability to resist smoking on a momentary basis, were more likely to have 
a first drink compared to those with higher confidence and compared to those who were not 
smoking (Wald χ2=10.24, df=1, p=.001, OR=0.57, 95% CIs 0.40, 0.80).  
----------------------------- 
Insert Table 2 and Figure 2 about here 
----------------------------- 
Predictors of Smoking Lapse 
Table 3 shows the results of the random effects logistic regression analyses conducted 
using first cigarette in the 14-day post-quit monitoring period as the dependent variable. Positive, 
high activation mood, confidence to resist smoking, and urge to smoke emerged as significant 
momentary predictors of first cigarette in the succeeding hours. As shown in Figure 3, those who 
had low positive mood (panel A), low momentary confidence in their ability to stop smoking 
(panel B), and higher urge to smoke (panel C) were significantly more likely to have their first 
cigarette prior to the next recording period. Although neither low activation negative mood nor 
high activation negative mood predicted smoking lapse, baseline negative affect predicted 
smoking lapse in the analyses including low activation negative mood (Wald χ2=4.39, df=1, 
p<.05, OR=1.13, 95% CIs 1.01, 1.28) and high activation negative mood (Wald χ2=4.37, df=1, 
p<.05, OR=1.14, 95% CIs 1.01, 1.28). 
----------------------------- 
Insert Table 3 and Figure 3 about here 
----------------------------- 
Distribution Characteristics of Momentary Variables 
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 We found it surprising that those variables related specifically to drinking failed to 
predict first drink in the monitoring period. One possibility for this is a floor or ceiling effect on 
the momentary predictor variables. To assess this possibility we looked at the distribution of the 
drinking-related variables. Table 4 shows the distribution characteristics of the variables 
aggregated over times and days for those records in the 28-day period that occurred before the 
first drink for the 29 patients who reported having a drink. Similarly, Table 5 shows the 
distribution characteristics of the momentary variables aggregated over times and days for those 
records in the post-quit 14-day period that occurred before the first cigarette for the 32 patients 
who reported a first cigarette. It is notable that in both tables the lowest mean score was for urge 
to drink and the highest mean score was for confidence to resist drinking.  
----------------------------- 
Insert Tables 4 and 5 about here 
----------------------------- 
Discussion 
 
Most previous research on concurrent alcohol and tobacco treatment has focused on 
outcomes, as opposed to the processes leading up to lapses and relapses. In addition, studies of 
smoking and drinking relapse largely have relied on retrospective or distant prospective 
measures of cognition or affect in predicting a lapse or relapse, or else have treated these 
variables as enduring, individual difference variables (Shiffman, 1989). The current study sought 
to address these shortcomings by using EMA methodology over a 28-day period during 
concurrent alcohol and tobacco treatment to elucidate intrapersonal proximal antecedents to 
initial smoking and drinking lapses, while simultaneously controlling for baseline measures of 
the study variables. Possible cross-substance predictions (e.g., smoking urge predicting drinking 
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lapse, drinking predicting smoking lapse) also were tested, as these may be especially salient 
among individuals in concurrent treatment. Our prospective analysis suggested that smoking 
relapse was foreshadowed by higher urges to smoke, lower positive high-activation mood, and 
lower confidence to resist smoking. Drinking lapse also was preceded by lower confidence to 
resist smoking, but only among individuals who were smoking in the period prior to the drinking 
lapse.   
Abstinence Self-Efficacy 
Confidence in one’s ability to resist smoking was a significant predictor of both smoking 
and drinking lapses. For every 1-point decrease on the 5-point smoking ASE scale, there was a 
near 30% increase in lapse hazard rate over the base hazard of smoking or drinking lapse. These 
findings are consistent with the cognitive-behavioral model of relapse and prior research 
employing EMA methods to examine smoking ASE and smoking relapse. For example, among 
participants in smoking cessation research clinics, daily smoking ASE predicted first smoking 
lapse on the next day even after controlling for differences in baseline ASE (Gwaltney et al., 
2005). Similarly, Van Zundert et al. (2010) noted that smoking ASE predicted first smoking 
lapse on the next day, also after controlling for differences in baseline ASE. Collectively, our 
research and previous research with both treatment-seeking and non-treatment-seeking 
individuals suggests that proximal declines in smoking ASE are an important and robust 
predictor of early smoking lapse and relapse.  
An unexpected finding in the current study was that smoking ASE, and not alcohol ASE, 
predicted initial drinking lapses. Furthermore, this association was apparent only among those 
who were smoking prior to the drinking lapse. In an earlier investigation by our research group, 
lower alcohol ASE assessed hours earlier predicted initial drinking lapses (smoking ASE was not 
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assessed in that study) (Cooney et al., 2007). Ceiling effects on the alcohol ASE measure, which 
have been observed in other studies (Cooney et al., 2007; Litt, Cooney, & Morse, 1998), might 
have precluded our ability to detect a relation between alcohol ASE and drinking lapse. Our 
finding that declining ASE for one substance predicted lapse to a different substance suggests the 
possibility that participants were experiencing a generalized decline in personal efficacy or self-
control strength prior to their first alcohol lapse. Perhaps the smoking ASE measure, with its 
better distributional properties, was better at capturing this generalized decline than the drinking 
ASE measure. The fact that those who stopped smoking evidenced a lower alcohol lapse risk 
lends confidence in recommending smoking cessation concurrent with alcohol treatment.  
Urge to Smoke or Drink 
As hypothesized, higher urge to smoke hours earlier predicted smoking lapse. The effect 
size for smoking urge was sizeable: For every 1-point increase on the 5-point confidence scale, 
there was a 51% increase in the hazard rate of lapse over the base hazard of smoking lapse. 
These findings are in line with previous research showing that increases in smoking urge hours 
earlier predicted first smoking lapse in individuals in concurrent smoking and alcohol treatment 
(Cooney et al., 2007), and with a study that used EMA methods to collect retrospective 
information about smoking urge prior to a smoking lapse (Shiffman et al., 1996).  
Contrary to our prediction, but in line with a previous study (Cooney et al., 2007), urge to 
drink was not a significant predictor of drinking lapse. An examination of the distribution of the 
drinking urge variable revealed possible floor effects, which might have precluded our ability to 
detect a relation between drinking urge and lapse to one or both substances. Other EMA studies 
with individuals in treatment also found that the frequency and intensity of alcohol craving was 
low (Cooney et al., 2007; Krahn, Henk, Grossman, & Gossnell, 2005; Litt, Cooney, & Morse, 
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2000; Litt et al., 1998; Lukasiewicz, Benyamina, Reynaud, & Falissard, 2005). There are several 
explanations that might account for low levels of reported drinking urge in this population. First, 
individuals in alcohol treatment settings may be less apt to experience urges because they are 
less likely to encounter cues that would trigger drinking urges (Rohsenow, 1999). Since patients 
in the current study were treated in an outpatient setting, however, it is likely that they would 
have readily encountered drinking cues outside the clinic. Other possibilities are that EMA 
methods do not sufficiently capture the experience of drinking urges, that recognizing an urge 
necessitates a higher level of self-awareness (Rohsenow, 1999) not yet developed among persons 
in treatment, that automatic processes, rather than conscious alcohol craving, determine initial 
alcohol relapse (Tiffany, 1990), or that urges (or the recognition of them) increased immediately 
prior to a lapse episode (Krahn et al., 2005) and thus were not detectable using lagged predictors 
obtained hours earlier.  
Positive and Negative Affect 
Low levels of positive high activation mood hours earlier predicted initial smoking 
lapses. Similar to the findings for smoking ASE and smoking urge, the effect size for positive 
affect was notable. For every 1-point decrease on the 5-point mood scale, there was a 49% 
increase in the hazard rate of smoking lapse over the base hazard rate. This finding was 
consistent with the affective processing model of negative reinforcement, which contends that 
the resumption of substance use serves to ameliorate low positive affect brought about by drug 
withdrawal (Baker et al., 2004). Low levels of positive affect may have been experienced as 
aversive and prompted a lapse, especially if study participants relied on tobacco or alcohol as a 
means of activating or energizing their mood or behavior. Our findings were not entirely 
consistent with the model, however, given that the model regards escape from negative affect as 
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the primary motivation for resumption of use, and we did not find evidence of a relation between 
increasing levels of negative low/high activation mood and lapse. Instead, our findings 
corresponded more closely to recent research, which has found that low positive affect is 
associated with an increased risk of smoking relapse (Cook, Spring, McChargue, & Doran, 2010; 
Doran, 2006; Leventhal et al., 2008).  
In the current study, high activation positive mood (i.e. happiness) was protective of 
smoking lapse, whereas low-activation positive mood, characterized by relaxation and quietness, 
was not. The literature generally corroborates our findings that high negative mood (Shiffman & 
Gwaltney, 2008; Oslin et al., 2009), or low positive mood (Strong et al., 2009) are predictive of 
relapses to substances of abuse. Generally these studies do not distinguish between low and high 
activation mood states.  In the present study, the relative lack of predictive power for low 
activation positive mood may have been attributable to the lack of distinctiveness between low 
activation positive mood and negative mood. Whereas high-activation positive mood was 
strongly negatively correlated with negative mood (r = -.40), low activation positive mood was 
not (r =-.08). Thus, it may be the case that happiness is more protective than simple relaxation. 
Given that the cognitive-behavioral and affective processing models of relapse regard 
negative affect as one of the key factors in the resumption of substance use, it is surprising that 
the current study did not find a relation between momentary measures of negative affect and 
smoking or drinking lapse. Research employing EMA methods to study smoking lapses has 
found that prospective measures of negative affect (Cooney et al., 2007) and retrospective 
measures (Shiffman et al., 1996) were associated with smoking lapses. This has not always been 
the case, however (Shiffman, 2009). The observed relation between baseline negative affect and 
smoking lapse in the current study was consistent with the findings of Berlin and Covey (2006), 
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who found that pre-cessation depressive symptoms served as a risk factor for smoking relapse. 
Future research should continue to collect both proximal and distal measures of affect, and 
should examine changes in both negative and positive affect as possible predictors of lapse.  
The cross-substance prediction observed has implications for the provision of concurrent 
treatment. In light of the observed associated between smoking ASE and drinking lapses in the 
current study, especially among those who are smoking, it would be advisable to work with 
persons in concurrent treatment to enhance their confidence to abstain from cigarettes, as well as 
from drinking. Given the small number of cross-substance interactions and the fact that alcohol 
use alone did not appear to trigger smoking lapses (and vice versa), concurrent treatment would 
still be advisable for individuals with alcohol and tobacco dependence.  
The current study had numerous strengths, in that it elucidated the extent to which 
proximal cognitive-behavioral processes were associated with smoking and drinking lapses in a 
population of individuals rarely studied. Within-subjects analyses were employed, which 
permitted an examination of how unique changes in intrapersonal variables affected one’s risk of 
smoking and drinking lapse. Since both baseline measures and EMA lagged predictor variables 
were included in the analyses, the significant relations between the EMA measures and 
smoking/drinking lapses reflect unique within-subject variation in the hours prior to a lapse, as 
opposed to baseline differences between participants.   
Several limitations to this study should be noted. First, the sample size was small due to 
the fact that EMA measures were obtained for only two weeks in the case of smoking lapse and 
four weeks in the case of drinking lapse and only a small percentage of participants lapsed to one 
or both substances during that time. However, according to Kreft and DeLeeuw (1998), the 
power for multilevel models like these is determined by both the number of level 1 (i.e., days) 
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and level 2 (i.e., persons) units. Although the number of participants was relatively small, a large 
number of records (N=1026) was examined, providing for large power. Second, we used single 
item measures of urge and confidence to abstain, which might account for limited variability 
observed in the alcohol urge and alcohol abstinence confidence variables. More extensive EMA 
measures of confidence to abstain from drinking and urge to drink should be considered for 
future research. Third, compliance with the EMA protocol was somewhat lower than previous 
EMA studies of persons in tobacco treatment, but was comparable to studies with persons in 
alcohol treatment (Cooney et al., 2007).  
Data from this subset of individuals may not generalize to all people in concurrent 
treatment, especially those who experience an initial lapse later in treatment or following the 
conclusion of treatment. Moreover, the brief EMA monitoring period only allows for an 
examination of the initial lapses, as opposed to an examination of processes that are involved in 
the progression from lapse to relapse. A longer monitoring period would permit a more 
comprehensive examination of the relapse process. Finally, the cognitive-behavioral model of 
relapse assigns a causal role to ASE, mood, and urges, but this study did not experimentally 
manipulate these processes, so it cannot be assumed that process changes caused smoking and 
drinking lapses.  
Reactivity to the EMA measures could have affected participants’ reports of the variables 
under study. However, research largely has shown that while reactivity to EMA methods is 
possible (Rowan et al., 2007), it may be more common when the phenomenon of interest is a 
behavior (as opposed to a cognition), specifically one that an individual wishes to alter (Shiffman 
et al., 2008). Moreover, several EMA studies have detected little to no reactivity among 
substance users (Hufford, Shields, Shiffman, Paty, & Balabanis, 2002; Litt et al., 1998; Simpson, 
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Kivlahan, Bush, & McFall, 2005). A review by Barta, Tennen and Litt (in press) concluded that 
when multiple behaviors and cognitions are monitored, and demand for change is minimized, 
reactivity to monitoring is reduced. Although our study design did not allow us to assess for 
reactivity, research would suggest that it did not considerably alter the findings. 
 This is the second study conducted by our research group that examined proximal 
antecedents to relapse in the context of concurrent alcohol and tobacco treatment. The first study 
(Cooney et al., 2007) also used randomly-timed signal contingent EMA assessments to examine 
lag predictors of smoking and drinking relapse. However, in the earlier study, EMA data 
collection began after the completion of a three-week intensive outpatient alcohol and tobacco 
treatment, with participants reporting a mean of 28 days alcohol abstinence at the outset of EMA 
collection, as compared to the present study with EMA data collection beginning at the very start 
of low intensity (weekly sessions) outpatient treatment. Also, the earlier study did not assess 
smoking abstinence self-efficacy, and the analysis did not control for baseline measures of the 
lagged predictor variables. In spite of these differences, both studies found that urge to smoke 
predicted smoking lapse and both found evidence for cross-substance predictive relations. The 
earlier study found that urge to smoke predicted both smoking and alcohol lapse while the 
present study found smoking abstinence self-efficacy predicted both smoking and alcohol lapse. 
Taken together, these two studies suggest that relapse theory needs to consider cross-substance 
processes in the context of concurrent treatment of multiple addictive behaviors. Advancing the 
research on the experiences of people in concurrent treatment may lead to more efficacious 
treatments and perhaps more widespread implementation of this treatment approach.   
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Table 1 
 
Baseline participant characteristics (N=96) 
 
Characteristic M (or %) SD 
 
Age (M, SD) 44.96 10.10 
Sex (%)    
    Males 70.80  
    Females 26.40  
Race (%)   
    Caucasian 89.60  
    African American 5.20  
    Hispanic 3.10  
    Other (bi-racial) 2.10  
Education (%)   
    Grade/High school 62.50  
    College degree 37.50  
Veteran (%) 31.30  
Baseline cigarettes/day (M, SD) 25.48 9.73 
Carbon monoxide (M, SD) 29.70 13.43 
Fagerstrom Test of Nicotine Dependence (FTND) 6.46 2.56 
Baseline PDA (M, SD) 0.28 0.27 
Baseline PDH (M, SD) 0.57 0.31 
Other drug use (%)   
     Cocaine 4.30  
     Cannabis 16.00  
Center for Epidemiological Studies Depression scale  
     (CES-D) (M, SD) 
 
17.35 
 
7.44 
CES-D (% who met cutoff) 59.40  
Profile of Mood States – Vigor Activity Scale (POMS) 12.90 4.83 
Smoking Self-Efficacy Total Score (SSET) 65.11 6.53 
Alcohol Abstinence Self-Efficacy (AASE) 7.95 28.50 
Questionnaire on Smoking Urges Total (QSU) 137.32 35.94 
Penn Alcohol Carving Scale Total (PACS) 14.04 6.82 
Minnesota Withdrawal Scale 13.82 7.58 
 
Note. PDA=Proportion Days Abstinent from Alcohol in the previous 90 days; PDH= Proportion 
of days in the previous 90 in which heavy drinking was reported. 
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Table 2 
 
Summary of Results of Random Effects Logistic Regression Analyses.  
 
Dependent Variable = 1st Drink during 28-Day Monitoring Period. All analyses controlled for  
 
recording day, time of day, and day X time. (N=29 events; 658 records).
Lagged Predictor B SE B Wald 
Chi-squarea 
Odds 
Ratio 
95% CI for OR 
Lower      Upper 
Negative – Low Activation Moodb .093 .248 0.14 1.10 0.68 1.79 
Negative – High Activation Moodb .292 .206 2.00 1.34 0.89 2.01 
Positive – Low Activation Moodc -.091 .204 0.66 0.91 0.61 1.36 
Positive – High Activation Moodc .247 .280 0.78 1.28 0.74 2.22 
Confidence to Resist Smokingd -.331 .103 10.25*** 0.72 0.59 0.88 
Confidence to Resist Drinkinge -.117 .122 0.92 0.89 0.70 1.13 
Urge to Smokef -.177 .129 1.88 0.84 0.65 1.08 
Urge to Drinkg .225 .134 2.83 1.25 0.96 1.63 
Withdrawal Symptomsh .233 .244 0.91 1.26 0.78 2.04 
Smoked (Yes/No) -.409 .310 1.74 0.66 0.36 1.22 
Note. *p < .05; ** p < .01; ***p < .001 
a1Degree-of-freedom tests 
bAnalysis controlled for baseline CES-D depressed affect subscale score 
cAnalysis controlled for baseline POMS vigor score 
dAnalysis controlled for  baseline SSET score 
eAnalysis controlled for baseline AASE score 
fAnalysis controlled for baseline QSU desire score 
gAnalysis controlled for baseline PACS score 
hAnalysis controlled for baseline Minnesota withdrawal scale score 
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Table  3 
 
Summary of Results of Random Effects Logistic Regression Analyses.  
Dependent Variable = 1st Cigarette During 14-Day Post-Quit Monitoring Period.  All analyses  
 
controlled for recording day, time of day, and day X time. (N=32 events; 368 records). 
 
Lagged Predictor B SE B Wald 
Chi-squarea 
Odds 
Ratio 
95% CI for OR  
Lower      Upper 
Negative – Low Activation Moodb -.284 .288 0.98 0.75 0.43 1.32 
Negative – High Activation Moodb -.056 .282 0.04 0.95 0.54 1.65 
Positive – Low Activation Moodc .012 .296 0.00 1.01 0.57 1.81 
Positive – High Activation Moodc -.667 .232    8.30** 0.51 0.33 0.81 
Confidence to Resist Smokingd -.364 .185  3.89* 0.70 0.48 0.99 
Confidence to Resist Drinkinge  -.147 .136 1.17 0.86 0.66 1.13 
Urge to Smokef .392 .173  5.11* 1.48 1.05 2.08 
Urge to Drinkg -.033 .283 0.01 0.97 0.56 1.68 
Withdrawal Symptomsh .207 .380 0.30 1.23 0.58 2.59 
Drank (Yes/No) .387 .824 0.22 1.47 0.29 7.40 
Note. *p < .05; ** p < .01; ***p < .001 
a1Degree-of-freedom tests 
bAnalysis controlled for baseline CES-D depressed affect subscale score 
cAnalysis controlled for baseline POMS vigor score 
dAnalysis controlled for baseline SSET score 
eAnalysis controlled for baseline AASE score 
fAnalysis controlled for baseline QSU desire score 
gAnalysis controlled for baseline PACS score 
hAnalysis controlled for baseline Minnesota withdrawal scale score 
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Table 4 
Distribution Statistics of Aggregated Momentary Variables Recorded in the Records Prior to 
First Drink (n=29 events; 658 records) 
Momentary Measure M SD Median Minimum Maximum Skewness 
Negative-Low Arousal Mood 2.26 .67 2.00 1.32 3.94 .98 
Negative-High Arousal Mood 2.11 .66 2.05 1.09 3.23 .07 
Positive-Low Arousal Mood 2.66 .52 2.62 1.75 3.88 .79 
Positive-High Arousal Mood 2.84 .74 2.88 1.58 4.52 .27 
Urge to Smoke 3.21 .95 3.18 1.62 4.89 -.12 
Urge to Drink 1.62 .55 1.48 1.00 2.85 .78 
Confidence Resist Smoking 2.50 .83 2.32 1.36 4.31 .46 
Confidence Resist Drinking 3.97 .82 4.19 1.54 4.95 -1.21 
Withdrawal Symptoms 2.28 .53 2.40 1.42 3.17 -.14 
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Table 5  
Distribution Statistics of Aggregated Momentary Variables Recorded in the Records Prior to 
First Cigarette (n=32 events; 368 records) 
Momentary Measure M SD Median Minimum Maximum Skewness 
Negative-Low Arousal Mood 2.36 .78 2.50 1.00 4.50 .34 
Negative-High Arousal Mood 2.26 .74 2.00 1.00 4.33 .76 
Positive-Low Arousal Mood 2.62 .76 2.59 1.00 4.75 .51 
Positive-High Arousal Mood 2.65 .70 2.62 1.17 4.33 .34 
Urge to Smoke 2.25 1.27 2.00 1.00 5.00 .66 
Urge to Drink 1.51 .99 1.00 1.00 5.00 2.65 
Confidence Resist Smoking 3.32 1.31 3.00 1.00 5.00 -.21 
Confidence Resist Drinking 4.03 1.25 4.61 1.00 5.00 -1.28 
Withdrawal Symptoms 2.32 .66 2.31 1.00 4.00 .33 
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Week number 
 
0 1 2 3 4 5 6 7 8 6 7 8 9 10 11 12 13 
 
Screening, alcohol cessation and detoxification if necessary, baseline assessments 
                 
                 
       Alcohol and tobacco counseling sessions* 
                 
                 
                                 Smoking quit date 
                 
                 
                Electronic Diary Assessment (EMA) 
                 
 
Figure 1. Weekly timeline for concurrent alcohol and tobacco treatment and assessments.  
*Additional counseling sessions were provided at weeks 17, 21, and 25. 
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Figure 2. Relation between aggregated momentary confidence to resist smoking and probability 
of an initial drinking lapse at the next time point by smoking status. Probability estimates derived 
from GEE analyses. Among those who reported any smoking in the days prior to their first 
drinking lapse, lower momentary confidence to resist smoking was associated with a higher 
probability of initial drinking lapse occurring at the succeeding time point.   
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Figure 3. Relation between aggregated high activation mood, confidence to resist smoking, and 
urge to smoke, and probability of an initial smoking lapse at the next time point. Probability 
estimates derived from GEE analyses. Higher momentary positive-high activation mood and 
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higher momentary confidence to resist smoking were independently associated with lower 
probability of an initial smoking lapse occurring at the succeeding time point. Higher momentary 
urge to smoke was associated with a higher probability of an initial smoking lapse occurring at 
the succeeding time point. 
 
